Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Sonja M Best"'
Autor:
Xueqiao Liu, Hong-Su Park, Yumiko Matsuoka, Celia Santos, Lijuan Yang, Cindy Luongo, Ian N Moore, Reed F Johnson, Nicole L Garza, Peng Zhang, Paolo Lusso, Sonja M Best, Ursula J Buchholz, Cyril Le Nouën
Publikováno v:
PLoS Pathogens, Vol 19, Iss 6, p e1011057 (2023)
The pediatric live-attenuated bovine/human parainfluenza virus type 3 (B/HPIV3)-vectored vaccine expressing the prefusion-stabilized SARS-CoV-2 spike (S) protein (B/HPIV3/S-2P) was previously evaluated in vitro and in hamsters. To improve its immunog
Externí odkaz:
https://doaj.org/article/eb32882f2f894b40aeab331f51b202e1
Autor:
Rosa C Coldbeck-Shackley, Ornella Romeo, Sarah Rosli, Linden J Gearing, Jodee A Gould, San S Lim, Kylie H Van der Hoek, Nicholas S Eyre, Byron Shue, Sarah A Robertson, Sonja M Best, Michelle D Tate, Paul J Hertzog, Michael R Beard
Publikováno v:
PLoS Pathogens, Vol 19, Iss 3, p e1010843 (2023)
The immunological surveillance factors controlling vulnerability of the female reproductive tract (FRT) to sexually transmitted viral infections are not well understood. Interferon-epsilon (IFNɛ) is a distinct, immunoregulatory type-I IFN that is co
Externí odkaz:
https://doaj.org/article/5466e29dbea44bb9bb2a994a75c3a117
Autor:
Rebecca M Broeckel, Friederike Feldmann, Kristin L McNally, Abhilash I Chiramel, Gail L Sturdevant, Jacqueline M Leung, Patrick W Hanley, Jamie Lovaglio, Rebecca Rosenke, Dana P Scott, Greg Saturday, Fadila Bouamr, Angela L Rasmussen, Shelly J Robertson, Sonja M Best
Publikováno v:
PLoS Pathogens, Vol 17, Iss 12, p e1009678 (2021)
Kyasanur Forest disease virus (KFDV) and the closely related Alkhurma hemorrhagic disease virus (AHFV) are emerging flaviviruses that cause severe viral hemorrhagic fevers in humans. Increasing geographical expansion and case numbers, particularly of
Externí odkaz:
https://doaj.org/article/e75b0f0e8a774ab2b7bf41f32357fe43
Autor:
Claude Kwe Yinda, Julia R Port, Trenton Bushmaker, Irene Offei Owusu, Jyothi N Purushotham, Victoria A Avanzato, Robert J Fischer, Jonathan E Schulz, Myndi G Holbrook, Madison J Hebner, Rebecca Rosenke, Tina Thomas, Andrea Marzi, Sonja M Best, Emmie de Wit, Carl Shaia, Neeltje van Doremalen, Vincent J Munster
Publikováno v:
PLoS Pathogens, Vol 17, Iss 1, p e1009195 (2021)
SARS-CoV-2 emerged in late 2019 and resulted in the ongoing COVID-19 pandemic. Several animal models have been rapidly developed that recapitulate the asymptomatic to moderate disease spectrum. Now, there is a direct need for additional small animal
Externí odkaz:
https://doaj.org/article/798ae271b60d4475a045eac12954dcfe
Autor:
Adaeze O Izuogu, Kristin L McNally, Stephen E Harris, Brian H Youseff, John B Presloid, Christopher Burlak, Jason Munshi-South, Sonja M Best, R Travis Taylor
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179781 (2017)
Tick-borne flaviviruses (TBFVs), including Powassan virus and tick-borne encephalitis virus cause encephalitis or hemorrhagic fevers in humans with case-fatality rates ranging from 1-30%. Despite severe disease in humans, TBFV infection of natural ro
Externí odkaz:
https://doaj.org/article/5bf74743187f459c9d747618a6488809
Autor:
Zhigang Yi, Lindsey Sperzel, Cindy Nürnberger, Peter J Bredenbeek, Kirk J Lubick, Sonja M Best, Cristina T Stoyanov, Lok Man J Law, Zhenghong Yuan, Charles M Rice, Margaret R MacDonald
Publikováno v:
PLoS Pathogens, Vol 7, Iss 1, p e1001255 (2011)
Viruses in the Flavivirus genus of the Flaviviridae family are arthropod-transmitted and contribute to staggering numbers of human infections and significant deaths annually across the globe. To identify cellular factors with antiviral activity again
Externí odkaz:
https://doaj.org/article/bff01d06ed4c4506a6daef1243d5de93
Autor:
Charalampos Valmas, Melanie N Grosch, Michael Schümann, Judith Olejnik, Osvaldo Martinez, Sonja M Best, Verena Krähling, Christopher F Basler, Elke Mühlberger
Publikováno v:
PLoS Pathogens, Vol 6, Iss 1, p e1000721 (2010)
Previous studies have demonstrated that Marburg viruses (MARV) and Ebola viruses (EBOV) inhibit interferon (IFN)-alpha/beta signaling but utilize different mechanisms. EBOV inhibits IFN signaling via its VP24 protein which blocks the nuclear accumula
Externí odkaz:
https://doaj.org/article/53ce7d4b6a424ce9940d05a05fa5ce90
Autor:
Yongli Xiao, Paul A. Beare, Sonja M. Best, David M. Morens, Marshall E. Bloom, Jeffery K. Taubenberger
Publikováno v:
Scientific Reports. 13
Rocky Mountain spotted fever (RMSF) is a rapidly progressive and often fatal tick-borne disease caused by Rickettsia rickettsii. Its discovery and characterization by Howard Ricketts has been hailed as a remarkable historical example of detection and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a73f7f695c11b3dbb7d62fda5e851f2
https://doi.org/10.1038/s41598-023-31894-0
https://doi.org/10.1038/s41598-023-31894-0
Autor:
Xueqiao Liu, Hong-Su Park, Yumiko Matsuoka, Celia Santos, Lijuan Yang, Cindy Luongo, Ian N. Moore, Reed F. Johnson, Nicole L. Garza, Peng Zhang, Paolo Lusso, Sonja M. Best, Ursula J. Buchholz, Cyril Le Nouën
Publikováno v:
bioRxiv
The pediatric live-attenuated bovine/human parainfluenza virus type 3 (B/HPIV3)-vectored vaccine expressing the prefusion-stabilized SARS-CoV-2 spike (S) protein (B/HPIV3/S-2P) was previously evaluatedin vitroand in hamsters. To improve its immunogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3721ef1013f8873f40bc2a63d0b8439
https://doi.org/10.1101/2022.12.12.520032
https://doi.org/10.1101/2022.12.12.520032
Autor:
Shelly J, Robertson, Sonja M, Best
Publikováno v:
Immunity. 55:382-384
Macrophage activation is essential for effective immunity to infection but can also contribute to disease through incompletely understood mechanisms. In this issue of Immunity, Simpson et al. reveal that death of activated macrophages integrates extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5a738492d6222adb41af93fc270bc3f
https://doi.org/10.1016/j.immuni.2022.02.010
https://doi.org/10.1016/j.immuni.2022.02.010